• Identify vascular neurology articles for American Board of Psychiatry and Neurology maintenance of certification
  • Describe a framework to assess the quality of evidence in a review publication and publication for treatment of disease.
  • Identify use of LDL targets for secondary stroke prevention.
  • Describe efficacy of dabigatran for the treatment of cerebral venous thrombosis
  • Describe treatment effect for tenecteplase in stroke with large vessel occlusion.
  • Discuss imaging guided parameters to select patients for thrombolysis treatment with unknown time of onset
Session date: 
06/05/2023 - 4:00pm to 5:00pm CDT
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1221
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 

Please login or register to take this course.
Discloser List CME Internal Report